moxisylyte has been researched along with Arteriosclerosis in 1 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thomas, M | 1 |
| Campbell, H | 1 |
| Heard, GE | 1 |
1 trial available for moxisylyte and Arteriosclerosis
| Article | Year |
|---|---|
Evaluation of oral thymoxamine in patients with peripheral vascular occlusion of the lower limbs.
Topics: Administration, Oral; Arteriosclerosis; Blood Pressure; Clinical Trials as Topic; Humans; Leg; Moxis | 1973 |